Effects of several 5?-carboxamide derivatives of adenosine on adenosine receptors of human platelets and rat fat cells
- 1 January 1984
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 327 (1), 36-42
- https://doi.org/10.1007/bf00504989
Abstract
The effects of several 5′-carboxamide derivatives of adenosine on stimulatory (Ra) adenosine receptors of human platelets and inhibitory (Ri) adenosine receptors of rat fat cells have been compared. 5′-N-Cyclopropylcarboxamidoadenosine (CPCA) and 5′-N-ethylcarboxamidoadenosine (NECA) most potently inhibited ADP-induced aggregation of human platelets as shown by IC50-values of 0.24 and 0.34 μmol/l. 5′-N-Methylcarboxamidoadenosine (MECA; IC50 0.81 μmol/l) and 5′-N-carboxamidoadenosine (NCA; IC50 2.1 μmol/l) were less potent, whereas adenosine, 2-chloroadenosine and (-)N6-phenylisopropyladenosine [(-)PIA] exhibit IC50-values of about 1.5 μmol/l. Nearly the same rank order of potency was obtained for stimulation of adenylate cyclase activity of platelet membranes and for inhibition of [3H]NECA binding to human platelets. In order to examine the effects of the carboxamide analogues on Ri adenosine receptors of rat fat cells inhibition of lipolysis and adenylate cyclase were studied. (-)PIA was the most potent inhibitor of lipolysis as shown by an IC50 of 0.5 nmol/l, followed by CPCA (IC50 1.1 nmol/l) and NECA (IC50 1.3 nmol/l), whereas MECA (IC50 17.9 nmol/l) and NCA (IC50 20.1 nmol/l) were much less potent than NECA in inhibiting lipolysis. Similar results were obtained for inhibition of adenylate cyclase activity of fat cell membranes and for competition with [3H]PIA binding to fat cell membranes. The relative potencies of the adenosine analogues at both receptor subclasses were calculated from the ratio of the IC50-values for inhibition of platelet aggregation and of lipolysis. (-)PIA showed the highest selectivity for R i receptors as indicated by a 2,900-fold lower IC50 for the antilipolytic than for the antiaggregatory effect. The Ra/Ri activity ratio for NECA was about 260, for CPCA 220, for NCA 105 and for MECA 45. These results indicate that all 5′-carboxamide adenosine derivatives are more potent agonists at Ri receptors than at Ra receptors. Since MECA has a higher selectivity for Ra receptors than NECA, it may be useful for the characterization of stimulatory adenosine receptors in different tissues.Keywords
This publication has 36 references indexed in Scilit:
- Ra Adenosine receptors in human plateletsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
- Inhibition of brain adenylate cyclase by A1 adenosine receptors: Pharmacological characteristics and locationsBrain Research, 1983
- Functional identification of adenylate cyclase-coupled adenosine receptors in rat brain microvesselsEuropean Journal of Pharmacology, 1982
- Adenosine receptors in the central nervous system: Relationship to the central actions of methylxanthinesLife Sciences, 1981
- 5′‐N‐ETHYLCARBOXAMIDOADENOSINE: A POTENT INHIBITOR OF HUMAN PLATELET AGGREGATIONBritish Journal of Pharmacology, 1981
- Interaction of Clonidine and Clonidine Analogues with α‐Adrenergic Receptors of Neuroblastoma × Glioma Hybrid Cells and Rat BrainEuropean Journal of Biochemistry, 1981
- CARDIOVASCULAR EFFECTS OF NUCLEOSIDE ANALOGSAnnals of the New York Academy of Sciences, 1975
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- PREPARATION AND CHARACTERIZATION OF A PLASMA MEMBRANE FRACTION FROM ISOLATED FAT CELLSThe Journal of cell biology, 1970
- RAPID METHOD FOR ESTIMATION OF GLYCEROL IN FERMENTATION SOLUTIONSCanadian Journal of Research, 1950